87 related articles for article (PubMed ID: 6230179)
1. Measurement of heparan sulphate in normal human serum by laser nephelometry.
Warren C; Manley G
Clin Chim Acta; 1984 Mar; 137(3):355-9. PubMed ID: 6230179
[No Abstract] [Full Text] [Related]
2. Laser nephelometric determination of glycosaminoglycans--method and application.
Gressner AM; Scherer R; Stuhlsatz HW
J Clin Chem Clin Biochem; 1983 Jul; 21(7):407-16. PubMed ID: 6619739
[TBL] [Abstract][Full Text] [Related]
3. Heparitinases facilitate separation of disaccharides of heparan sulfate isomers in human arteries using high-performance liquid chromatography.
Murata K; Yokoyama Y; Yoshida K
Biochem Int; 1989 Jul; 19(1):155-62. PubMed ID: 2528351
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum glycosaminoglycans by laser nephelometry.
Warren C; Manley G
Clin Chim Acta; 1981 Nov; 116(3):369-80. PubMed ID: 6794960
[TBL] [Abstract][Full Text] [Related]
5. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
[TBL] [Abstract][Full Text] [Related]
6. Measurement of urinary mucopolysaccharides.
du Plooy M; de Villiers LS
S Afr Med J; 1975 Jun; 49(26):1038-40. PubMed ID: 125458
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycan changes involved in polymorphonuclear leukocyte activation in vitro.
Vannucchi S; Fibbi G; Cappelletti R; Del Rosso M; Chiarugi V
J Cell Physiol; 1982 May; 111(2):149-54. PubMed ID: 6806305
[TBL] [Abstract][Full Text] [Related]
8. Modification of plasma glycosaminoglycans in long distance runners.
Contini M; Pacini S; Ibba-Manneschi L; Boddi V; Ruggiero M; Liguri G; Gulisano M; Catini C
Br J Sports Med; 2004 Apr; 38(2):134-7; discussion 137. PubMed ID: 15039246
[TBL] [Abstract][Full Text] [Related]
9. Action pattern of polysaccharide lyases on glycosaminoglycans.
Jandik KA; Gu K; Linhardt RJ
Glycobiology; 1994 Jun; 4(3):289-96. PubMed ID: 7949654
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S
J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of individual glycosaminoglycans in plasma by concanavalin A rocket electrophoresis.
Staprans I; Felts JM; Butts RJ
Anal Biochem; 1983 Oct; 134(1):240-4. PubMed ID: 6660493
[TBL] [Abstract][Full Text] [Related]
12. Protein-bound glycosaminoglycans in serum of patients with lung cancer and patients with diabetes mellitus.
Olczyk K; Kucharz EJ; Głowacki A; Sonecki P; Kościelniak-Kocurek E
Acta Biochim Pol; 1992; 39(1):101-5. PubMed ID: 1441821
[No Abstract] [Full Text] [Related]
13. Low urinary excretion of heparan sulfate in three patients with Lowe's syndrome.
Yokoi T; Uozaki T; Kasei M; Sato T; Taniguchi N
Clin Chim Acta; 1981 Oct; 116(2):153-60. PubMed ID: 6457705
[TBL] [Abstract][Full Text] [Related]
14. Isolation of glycosaminoglycans from lymphocytes in chronic lymphoic leukemia.
Capeau J; Picard J; Paul-Gardais A
Biomedicine; 1978 May; 28(2):124-9. PubMed ID: 307408
[TBL] [Abstract][Full Text] [Related]
15. Degradative removal of heparan sulfate from the surface of an ascites hepatoma, AH 66, by heparitinase.
Ohkubo Y; Funakoshi I; Yamashina I
J Biochem; 1981 Jan; 89(1):161-7. PubMed ID: 6452448
[TBL] [Abstract][Full Text] [Related]
16. Oligosaccharide mapping of heparan sulphate by polyacrylamide-gradient-gel electrophoresis and electrotransfer to nylon membrane.
Turnbull JE; Gallagher JT
Biochem J; 1988 Apr; 251(2):597-608. PubMed ID: 2969727
[TBL] [Abstract][Full Text] [Related]
17. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
[TBL] [Abstract][Full Text] [Related]
18. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.
Khoory MS; Nesheim ME; Bowie EJ; Mann KG
J Clin Invest; 1980 Mar; 65(3):666-74. PubMed ID: 6444419
[TBL] [Abstract][Full Text] [Related]
19. Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder.
Palmer RN; Rick ME; Rick PD; Zeller JA; Gralnick HR
N Engl J Med; 1984 Jun; 310(26):1696-9. PubMed ID: 6233489
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycans in the blood of hereditary multiple exostoses patients: Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
Anower-E-Khuda MF; Matsumoto K; Habuchi H; Morita H; Yokochi T; Shimizu K; Kimata K
Glycobiology; 2013 Jul; 23(7):865-76. PubMed ID: 23514715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
